The UNC Lineberger Comprehensive Cancer Center is a cancer research and treatment center at the University of North Carolina at Chapel Hill. One of 52 National Cancer Institute-designated comprehensive cancer centers in the United States, its clinical base is the N.C.

During the past decade, UNC Lineberger Comprehensive Cancer Center conducted 252 clinical trials. In the 10-year time frame, 252 clinical trials started and 222 clinical trials were completed, i.e. on average, 88.1% percent of trials that started reached the finish line to date. In the past 5 years, 53 clinical trials started and 90 clinical trials were completed. i.e. 169.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UNC Lineberger Comprehensive Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 173 trials, followed by "UNC Lineberger Comprehensive Cancer Center" with 153 trials sponsored, "Alliance for Clinical Trials in Oncology" with 112 trials sponsored, "Children's Oncology Group" with 111 trials sponsored and "Gynecologic Oncology Group" with 111 trials sponsored. Other sponsors include 237 different institutions and companies that sponsored additional 101 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UNC Lineberger Comprehensive Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 493 trials as a collaborator, "NRG Oncology" with 33 trials as a collaborator, "Cancer and Leukemia Group B" with 23 trials as a collaborator, "SWOG Cancer Research Network" with 20 trials as a collaborator and "Eastern Cooperative Oncology Group" with 17 trials as a collaborator. Other collaborators include 323 different institutions and companies that were collaborators in the rest 159 trials.

According to Clinical.Site data, the most researched conditions in "UNC Lineberger Comprehensive Cancer Center" are "Breast Cancer" (60 trials), "Leukemia" (57 trials), "Lung Cancer" (44 trials), "Lymphoma" (41 trials) and "Sarcoma" (32 trials). Many other conditions were trialed in "UNC Lineberger Comprehensive Cancer Center" in a lesser frequency.

Most popular intervention types in "UNC Lineberger Comprehensive Cancer Center" are "Drug" (661 trials), "Other" (280 trials), "Biological" (233 trials), "Procedure" (201 trials) and "Radiation" (174 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (142 trials), "radiation therapy" (80 trials), "Quality-of-Life Assessment" (73 trials), "Cyclophosphamide" (63 trials) and "Questionnaire Administration" (58 trials). Other intervention names were less common.

The vast majority of trials in "UNC Lineberger Comprehensive Cancer Center" are 656 trials for "All" genders, 169 trials for "Female" genders and 40 trials for "Male" genders.

Currently, there are NaN active trials in "UNC Lineberger Comprehensive Cancer Center". 3 are not yet recruiting, 112 are recruiting, 186 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 460 completed trials in UNC Lineberger Comprehensive Cancer Center, 10 suspended trials, and 72 terminated clinical trials to date.

Out of the total trials that were conducted in UNC Lineberger Comprehensive Cancer Center, 119 "Phase 1" clinical trials were conducted, 395 "Phase 2" clinical trials and 264 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 59 trials that are defined as “Not Applicable".